While aldosterone and MR signaling have been implicated in the components of the metabolic syndrome associated with obesity (52, 53), and MR blockade prevents obesity-induced metabolic syndrome in some animal models (54, 55), this relationship has not held true in human studies (56–58). Here, NR3C2 is linked to metabolic syndrome.